Meet
Reginald Williams

Reginald Williams leads teams that deliver research, analytic, and strategic support to clients, with a focus on the needs of life sciences manufacturers and patient groups.

He advises clients on medical technology policy, regulatory, and market access strategies for new products and the evolution of public and private payers' use of evidence for formulating coverage and reimbursement decisions, with a focus on the Medicare program.

Prior to joining Avalere, Reggie was a member of the health policy team at the National Academy of Social Insurance (NASI). He served as the Howard R. Swearer Public Service intern in the Rhode Island Department of Health's Office of Minority Health.

Reggie has an AB in biomedical ethics from Brown University. He serves on the board of directors of Mental Health America, a nonprofit dedicated to helping people live mentally healthier lives. He is a Patient-Centered Outcomes Research grant reviewer and a member of NASI and Health Technology Assessment International.

Authored Content


During the last week of October, Avalere invited a select group of innovators to breakfasts in Los Angeles and San Francisco to discuss elements of successful adoption of innovative technologies and models of care.

Earlier this week, BioCentury featured guest commentary from Tanisha Carino and Reginald Williams about patient engagement.

The 2014 market will be characterized by challenge and transformation across payers, providers, and patients which will create pressures for the pharmaceutical and medical device industries to:

Avalere convened a meeting of healthcare leaders who outlined four critical areas to sustain innovation: infrastructure, evidence evaluation, evidence communication, and coverage and payment.